Sabra(SBRA)

Search documents
Sabra(SBRA) - 2025 Q1 - Earnings Call Transcript
2025-05-06 18:02
Sabra Health Care REIT (SBRA) Q1 2025 Earnings Call May 06, 2025 01:00 PM ET Company Participants Lukas Hartwich - Executive Vice President FinanceRick Matros - Director, President, Chairman & CEOTalya Nevo-Hacohen - Executive VP, Chief Investment Officer & TreasurerMichael Costa - Executive VP, CFO & SecretaryElmer Chang - Equity Research AssociateFarrell Granath - Equity Research AssociateJuan Sanabria - Managing DirectorGeorgi Dinkov - Senior Equity Research AssociateRichard Anderson - Managing Director ...
Sabra(SBRA) - 2025 Q1 - Earnings Call Transcript
2025-05-06 17:00
Financial Data and Key Metrics Changes - For Q1 2025, normalized FFO per share was $0.35 and normalized AFFO per share was $0.37, compared to $0.34 and $0.35 in Q1 2024, representing a year-over-year increase of 79% for both metrics [14][15] - Cash rental income from the triple net portfolio totaled $90 million, up from $89 million in Q1 2024, despite the disposal of $115 million of real estate from the portfolio last year [15] - Cash NOI from the managed senior housing portfolio totaled $24.1 million, compared to $19.1 million in Q1 2024, driven by strong occupancy and margin gains [15][12] Business Line Data and Key Metrics Changes - Skilled nursing and triple net senior housing EBITDARM rent coverage reached new highs at 2.19 and 1.41, respectively, with behavioral health coverage at 3.77 [5] - Skilled occupancy increased by 80 basis points sequentially, while triple net senior housing occupancy rose by 50 basis points [6] - Revenue for the same store managed senior housing portfolio grew 6.3% year-over-year, with occupancy at 85.4% compared to 82.6% in Q1 2024 [11] Market Data and Key Metrics Changes - The domestic portfolio occupancy was 83%, gaining 340 basis points year-over-year, while the Canadian portfolio occupancy was 90.9%, adding 140 basis points [11] - RevPAR in the same store portfolio increased by 2.8% year-over-year, with Canadian RevPAR growing by 4.9% [11] - The company noted a robust deal pipeline, with over $200 million in awarded deals, which is more than the total for all of 2024 [7][8] Company Strategy and Development Direction - The company is focusing on internal and external growth opportunities in senior housing, with little new supply expected in the coming years [10] - Management emphasized a commitment to maintaining a balanced portfolio between senior housing and skilled nursing, avoiding large portfolio acquisitions to keep operations predictable [78] - The company is actively using its ATM program to raise equity for funding growth, with a focus on accretive capital [16][18] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about continued occupancy growth and potential Medicaid rate increases in the summer, which could enhance coverage [86] - The company is cautious about the skilled nursing facility (SNF) market due to challenges in structuring leases around underperforming assets [66][68] - Management believes that the current operating environment will allow for improved coverage and revenue growth, despite potential headwinds from provider taxes [85] Other Important Information - The Board of Directors declared a quarterly dividend of $0.30 per share, representing a payout of 81% of the first quarter normalized AFFO per share [19] - The company has ample liquidity of over $1 billion, consisting of unrestricted cash and available borrowings [18] Q&A Session Summary Question: Update on skilled nursing facility sale - Management confirmed that the expected $50 million skilled nursing facility sale is still on track, though regulatory hurdles have delayed the process [21] Question: Trajectory of RevPOR and expense growth - Management expects occupancy to rise, which will allow for increased pricing power, while expenses are anticipated to remain stable [22][23] Question: Guidance on acquisitions and SHOP performance - Management reiterated that acquisitions are not included in current guidance until closed, and reaffirmed expectations for low to mid-teens cash NOI growth [27][28] Question: Insights on transaction market and deal flow - Management noted a robust pipeline of deals, primarily in senior housing, with private equity firms as frequent sellers [31][33] Question: Details on $200 million of awarded deals - All awarded deals are domestic, primarily in the Eastern U.S., with growth potential embedded in the assets [40][41] Question: Changes in underwriting criteria - Management stated that underwriting criteria remain unchanged, focusing on cost of capital and accretive deals [60] Question: Concerns regarding SNF acquisitions - Management highlighted challenges in acquiring SNFs due to financial instability and the difficulty in structuring leases [66][68] Question: Expectations for SHOP occupancy cadence - Management anticipates an increase in occupancy as seasonal factors improve, particularly in Canadian assets [70] Question: Interest in large portfolio acquisitions - Management confirmed a commitment to smaller, more manageable deals to maintain operational simplicity and predictability [78] Question: Medicare reimbursement impacts - Management expressed confidence that Medicare will not be significantly impacted by current government budget discussions [97]
Sabra(SBRA) - 2025 Q1 - Earnings Call Presentation
2025-05-06 11:39
Strategic. Disciplined. Opportunistic. Investor Presentation | May 5, 2025 Disclaimers Forward-Looking Statements This presentation contains "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. These statements may be identified, without limitation, by the use of "expects," "believes," "intends," "should" or comparable terms or the negative thereof. Examples ...
Sabra (SBRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-05-06 00:05
For the quarter ended March 2025, Sabra Healthcare (SBRA) reported revenue of $183.54 million, up 10.1% over the same period last year. EPS came in at $0.37, compared to $0.11 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $181.82 million, representing a surprise of +0.95%. The company delivered an EPS surprise of +2.78%, with the consensus EPS estimate being $0.36.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall ...
Sabra(SBRA) - 2025 Q1 - Quarterly Report
2025-05-05 20:06
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-34950 SABRA HEALTH CARE REIT, INC. (Exact Name of Registrant as Specified in Its Charter) Maryland 27-2560479 ...
Sabra(SBRA) - 2025 Q1 - Quarterly Results
2025-05-05 20:05
Reconciliations of Non-GAAP Financial Measures March 31, 2025 (Unaudited) SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES FFO, Normalized FFO, AFFO and Normalized AFFO (dollars in thousands, except per share data) | | | | Three Months Ended March 31, | | | --- | --- | --- | --- | --- | | | | 2025 | | 2024 | | Net income | $ | 40,304 | $ | 26,254 | | Add: | | | | | | Depreciation and amortization of real estate assets | | 43,494 | | 42,914 | | Depreciation and amortization of real ...
Sabra Health Care REIT: 7% Yield And Aging Population Make It A Downturn-Ready Pick
Seeking Alpha· 2025-04-28 10:15
Tariff uncertainty is still lingering over the stock market. As we speak, the Dow Jones Index ( DJI ) is down over 1,000 points, while the S&P ( SP500 ) is down more than 100 (points).Contributing analyst to the iREIT+Hoya Capital investment group. The Dividend Collectuh is not a registered investment professional nor financial advisor and these articles should not be taken as financial advice. This is for educational purposes only and I encourage everyone to do their own due diligence. I'm a Navy veteran w ...
Sabra Health Care REIT: Come For Income, Stay For Growth
Seeking Alpha· 2025-03-19 18:41
Group 1 - iREIT+HOYA Capital focuses on income-producing asset classes that provide sustainable portfolio income, diversification, and inflation hedging [1] - The service offers a free two-week trial for potential investors to explore top ideas across exclusive income-focused portfolios [1] Group 2 - The analyst has over 14 years of investment experience and an MBA in Finance, focusing on defensive stocks with a medium- to long-term investment horizon [2] - The analyst holds a beneficial long position in SBRA shares through stock ownership, options, or other derivatives [3]
Sabra(SBRA) - 2024 Q4 - Earnings Call Transcript
2025-02-20 21:51
Financial Data and Key Metrics Changes - For Q4 2024, normalized FFO per share was $0.35 and normalized AFFO per share was $0.36, with normalized AFFO totaling $86.9 million, consistent with Q3 [26][28] - Year-over-year normalized AFFO per share growth was 7%, with full-year 2024 normalized FFO per share at $1.39 and normalized AFFO per share at $1.44 [28][29] - The net debt to adjusted EBITDA ratio improved to 5.27% as of December 31, 2024, a decrease from the previous quarter and nearly half a turn from the previous year [33] Business Line Data and Key Metrics Changes - The senior housing and skilled portfolio showed strong performance, with SHOP same-store occupancy up 80 basis points sequentially and cash NOI at 17.9% for the quarter [9][10] - Managed senior housing portfolio revenue grew 3.5% sequentially, with cash NOI growth of 5.4% and margin expansion of 50 basis points [18] - Cash NOI from the managed senior housing portfolio increased to $24.1 million, driven by same-store growth and a new property acquisition [27] Market Data and Key Metrics Changes - The skilled occupancy rate increased by 60 basis points sequentially, with EBITDARM coverage reaching an all-time high of 2.09% [10] - The Canadian communities within the same-store portfolio saw revenue growth of 10.6% year-over-year, while domestic portfolio occupancy grew by 2.8% [20][21] - Total expenses for the same-store portfolio rose 3.4% year-over-year, with labor costs increasing by 2.1% [21][22] Company Strategy and Development Direction - The company plans to build upon its successful 2024 strategy, anticipating a higher volume of deals in 2025, particularly in the skilled nursing space [11][12] - The focus will be on acquiring newer, nearly stabilized senior housing communities that offer care to residents, with a strategic shift towards increasing SHOP exposure [24][74] - The company is optimistic about its ability to withstand potential Medicaid cuts due to strong portfolio performance and robust lobbying efforts [12][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the political environment's impact on business, noting historical protections for the elderly population regarding Medicaid [13][14] - The company expects revenue growth to continue outpacing expense growth, leading to ongoing cash NOI growth [23] - Management highlighted a robust acquisition pipeline, with many opportunities arising from private equity firms looking to exit investments [52][54] Other Important Information - A quarterly cash dividend of $0.30 per share was declared, representing a payout of 83% of the fourth quarter normalized AFFO per share [34] - The company has ample liquidity of $980 million, consisting of cash and available borrowings under its revolving credit facility [33] Q&A Session Summary Question: What are your thoughts on the pacing of occupancy in the senior housing space for 2025? - Management noted that operators are balancing rate increases with occupancy growth, making it difficult to predict exact occupancy trends [36][40] Question: Are you seeing any impacts in pricing for skilled nursing facilities due to the current environment? - The transaction market for skilled nursing is robust, with significant competition from strategic buyers [41][43] Question: What has changed in the acquisition pipeline that gives you confidence for 2025? - The company is seeing higher deal volume and improved cost of capital, allowing for more favorable acquisition opportunities [48][50] Question: How do you expect cash NOI growth to trend in 2025? - Cash NOI growth for the same-store managed senior housing portfolio is expected to be in the low to mid-teens, with a conservative approach to growth assumptions [31][58] Question: Can you elaborate on the strategies operators are implementing to mitigate costs? - Operators have embraced digital marketing for recruitment and revamped onboarding processes to improve employee retention [66] Question: What is the current size of the cash basis tenant base? - The cash basis tenant pool is less than 5% of total NOI, with some sales in the quarter related to cash basis tenants [138][140]
Sabra (SBRA) Reports Q4 Earnings: What Key Metrics Have to Say
ZACKS· 2025-02-20 00:30
Core Insights - Sabra Healthcare (SBRA) reported revenue of $182.35 million for Q4 2024, marking an 11.6% year-over-year increase, with EPS of $0.36 compared to $0.07 a year ago [1] - The reported revenue fell slightly short of the Zacks Consensus Estimate of $183.22 million, resulting in a surprise of -0.48%, while the EPS met the consensus estimate [1] Revenue Breakdown - Interest and other income amounted to $9.41 million, slightly below the average estimate of $9.71 million, reflecting a year-over-year increase of 3.4% [4] - Resident fees and services generated $76.87 million, exceeding the estimated $75.05 million, representing a significant year-over-year increase of 25.5% [4] - Rental and related revenues were reported at $96.07 million, slightly below the average estimate of $96.34 million, with a year-over-year change of 3.3% [4] Stock Performance - Over the past month, Sabra's shares have returned -3.5%, contrasting with the Zacks S&P 500 composite's increase of 2.4% [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance against the broader market in the near term [3]